Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally
29 Sept 2026 · LiveMint Markets
Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare, Consumer Durables.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Stock Market Today LIVE: Sensex Falls Over 400 Points, Nifty 50 Below 22,700 Ahead Of RBI Policy; Titan, Asian Paints Decline
Why India could become a global hub for responsible digital assets innovation
Titan share price drops 5% after Q2FY27 update - Should you buy this Tata Group stock now? Here's what experts say
Titan reports 25% revenue growth in Q2FY27, jewellery sales up 21%
Top stocks to watch today: Inox Wind, Meesho, Titan, Ola Electric shares in focus on Wednesday, 7 October | Full list